Press Releases InMed Pharmaceuticals Reports First Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update November 8, 2019 Read More » InMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial November 5, 2019 Read More » InMed Pharmaceuticals to Report First Quarter Fiscal 2020 Financial Results and Business Update on November 8, 2019 November 4, 2019 Read More » InMed Pharmaceuticals to Present at the BIO Investor Forum October 18, 2019 Read More » InMed Pharmaceuticals to Present at the Regulatory Affairs Professionals Society’s annual conference September 23, 2019 Read More » InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update September 19, 2019 Read More » InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019 September 12, 2019 Read More » InMed Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference September 3, 2019 Read More » InMed Pharmaceuticals to Attend the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit August 29, 2019 Read More » InMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes August 2, 2019 Read More » InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors July 2, 2019 Read More » InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update May 15, 2019 Read More » InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019 May 8, 2019 Read More » InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology March 18, 2019 Read More » InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program March 13, 2019 Read More » InMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019 March 12, 2019 Read More » InMed Pharmaceuticals Appoints Dr. Steven M. Dinh to Scientific Advisory Board March 6, 2019 Read More » InMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update February 12, 2019 Read More » InMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business Update on February 12, 2019 February 5, 2019 Read More » InMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer January 11, 2019 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Next » Management Learn More Board of Directors Learn More Scientific Advisory Board Learn More Investor Alerts Sign up to receive news releases from InMed Pharmaceuticals. SIGN UP
InMed Pharmaceuticals Reports First Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update November 8, 2019 Read More »
InMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial November 5, 2019 Read More »
InMed Pharmaceuticals to Report First Quarter Fiscal 2020 Financial Results and Business Update on November 8, 2019 November 4, 2019 Read More »
InMed Pharmaceuticals to Present at the Regulatory Affairs Professionals Society’s annual conference September 23, 2019 Read More »
InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update September 19, 2019 Read More »
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019 September 12, 2019 Read More »
InMed Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference September 3, 2019 Read More »
InMed Pharmaceuticals to Attend the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit August 29, 2019 Read More »
InMed Pharmaceuticals Appoints Bruce S. Colwill, CPA, CA as Chief Financial Officer and Announces other Leadership Changes August 2, 2019 Read More »
InMed Pharmaceuticals Reports Third Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update May 15, 2019 Read More »
InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019 May 8, 2019 Read More »
InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology March 18, 2019 Read More »
InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program March 13, 2019 Read More »
InMed Pharmaceuticals to Present at the 31st Annual ROTH Conference on March 19, 2019 March 12, 2019 Read More »
InMed Pharmaceuticals Appoints Dr. Steven M. Dinh to Scientific Advisory Board March 6, 2019 Read More »
InMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D and Business Update February 12, 2019 Read More »
InMed Pharmaceuticals to Report Second Quarter Fiscal 2019 Financial Results and Business Update on February 12, 2019 February 5, 2019 Read More »
InMed Pharmaceuticals Announces the Appointment of Dr. Sazzad Hossain, PhD, MSc, as a Member of the Scientific Advisory Board and his Retirement as Chief Scientific Officer January 11, 2019 Read More »
